| Direct Competitor Comparison | |
|---|
| VRX | PVT1 | TEVA | PVT2 | Industry |
|---|
| Market Cap: | 25.84B | N/A | 33.52B | N/A | 6.86B |
|---|
| Employees: | 7,000 | 5,6391 | 45,948 | 8,5062 | 245.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.25 | N/A | -0.04 | N/A | 0.14 |
|---|
| Revenue (ttm):
| 3.76B | 2.62B1 | 20.12B | 4.20B2 | 200.00k |
|---|
| Gross Margin (ttm): | 0.75 | N/A | 0.53 | N/A | 0.50 |
|---|
| EBITDA (ttm): | 1.97B | N/A | 5.72B | N/A | -180.20M |
|---|
| Operating Margin (ttm):
| 0.26 | N/A | 0.21 | N/A | -0.45 |
|---|
| Net Income (ttm): | -130.63M | 196.20M1 | 1.73B | 304.30M2 | N/A |
|---|
| EPS (ttm): | -0.43 | N/A | 2.00 | N/A | N/A |
|---|
| P/E (ttm): | N/A | N/A | 19.64 | N/A | N/A |
|---|
| PEG (5 yr expected): | N/A | N/A | 1.11 | N/A | 132.95 |
|---|
| P/S (ttm): | 6.08 | N/A | 1.67 | N/A | 34,280.42 |
|---|
|
| Pvt1 = H. Lundbeck A/S | | TEVA = Teva Pharmaceutical Industries Limited | | Pvt2 = UCB S.A. | | Industry = Drug Delivery | | 1 = As of 2012 2 = As of 2011 |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.91 | 0.00 | 79.43B | 17.93 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 235.24 | 0.01 | 55.84B | 37.33 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 55.81 | 0.01 | 85.13B | 31.25 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 74.04 | 0.00 | 12.74B | 31.35 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.34 | -0.00 | 33.52B | 19.64 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 127.23 | -0.01 | 16.25B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.17 | -0.02 | 11.88B | 20.82 |
|---|
| Pfizer Inc. | PFE | 29.04 | -0.00 | 205.99B | 13.90 |
|---|
| Johnson & Johnson | JNJ | 86.82 | -0.00 | 243.87B | 23.58 |
|---|
| GlaxoSmithKline plc | GSK | 52.97 | 0.00 | 128.29B | 19.36 |
|---|
| Sanofi | SNY | 54.86 | 0.01 | 145.20B | 27.04 |
|---|
| Novartis AG | NVS | 74.36 | 0.01 | 182.72B | 18.87 |
|---|
| Roche Holding AG | RHHBY | 65.96 | 0.01 | 223.86B | 22.07 |
|---|
| AstraZeneca PLC | AZN | 52.17 | 0.00 | 65.21B | 11.54 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.76 | 0.01 | 58.86B | 11.51 |
|---|
| Bristol-Myers Squibb Company | BMY | 47.40 | 0.01 | 77.86B | 53.68 |
|---|
|
| News on Direct Competitors | |
|---|
No Direct Competitor ComparisionCurrency in USD. | |
|
9.80(13.12%) 25 May 1:30AM|After Hours
:
84.60